Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease. Review uri icon

Overview

abstract

  • Obesity is the primary risk factor for the pathogenesis of non-alcoholic fatty liver disease (NAFLD), the worldwide prevalence of which continues to increase dramatically. The liver plays a pivotal role in the maintenance of whole-body lipid and glucose homeostasis. This is mainly mediated by the transcriptional activation of hepatic pathways that promote glucose and lipid production or utilization in response to the nutritional state of the body. However, in the setting of chronic excessive nutrition, the dysregulation of hepatic transcriptional machinery promotes lipid accumulation, inflammation, metabolic stress, and fibrosis, which culminate in NAFLD. In this review, we provide our current understanding of the transcription factors that have been linked to the pathogenesis and progression of NAFLD. Using publicly available transcriptomic data, we outline the altered activity of transcription factors among humans with NAFLD. By expanding this analysis to common experimental mouse models of NAFLD, we outline the relevance of mouse models to the human pathophysiology at the transcriptional level.

publication date

  • July 9, 2020

Identity

PubMed Central ID

  • PMC7408131

Scopus Document Identifier

  • 85090754033

Digital Object Identifier (DOI)

  • 10.3892/ijmm.2018.3389

PubMed ID

  • 32660130

Additional Document Info

volume

  • 10

issue

  • 7